<?xml version="1.0" encoding="UTF-8"?>
<Label drug="stimate" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

  Infrequently, DDAVP  (r)  Injection has produced transient headache, nausea, mild abdominal cramps and vulval pain. These symptoms disappeared with reduction in dosage. Occasional facial flushing has been reported with the administration of DDAVP  (r)  Injection. Infrequently, high doses of intranasal DDAVP  (r)  have produced transient headache and nausea. Nasal congestion, rhinitis and flushing have also been reported occasionally along with mild abdominal cramps. These symptoms disappeared with reduction in dosage. Nosebleed, sore throat, cough and upper respiratory infections have also been reported.



 In addition to those listed above, the following have also been reported in clinical trials with  Stimate    (r)    Nasal Spray  : Somnolence, dizziness, itchy or light-sensitive eyes, insomnia, chills, warm feeling, pain, chest pain, palpitations, tachycardia, dyspepsia, edema, vomiting, agitation and balanitis.



 DDAVP  (r)  Injection (desmopressin acetate) has infrequently produced changes in blood pressure causing either a slight elevation or a transient fall with a compensatory increase in heart rate. Severe allergic reactions including anaphylaxis have been reported rarely with DDAVP  (r)  Injection.



   Post Marketing

  There have been rare reports of convulsions from hyponatremia associated with concomitant use of desmopressin and the following medications: oxybutynin and imipramine.



 See    WARNINGS    for the possibility of water intoxication, hyponatremia and coma.



   To report SUSPECTED ADVERSE REACTIONS, contact CSL Behring Pharmacovigilance at 1-866-915-6958 or FDA at 1-800-FDA-1088 or    www.fda.gov/medwatch.  
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
